| Structure | Chemical Name | CAS | MF |
|
FTY720-d4 Hydrochloride
|
1346604-90-7
|
C19H34ClNO2
|
|
N-Methyl-N-[2-chlorobenzyl)]-2-thiopheneethanaMine Hydrochloride
|
1346604-98-5
|
C14H17Cl2NS
|
|
Propafenone-d5 HCl
|
1346605-05-7
|
C21H23ClD5NO3
|
|
DL-Propylhexedrine-d3 Hydrochloride
|
1346605-06-8
|
C10H22ClN
|
|
Clopidogrel Impurity C
|
1346605-15-9
|
C16H18ClNO2S
|
|
8-Dechloro-10-chloro Loratadine
|
1346605-16-0
|
C22H23ClN2O2
|
|
Hesperetin-D3
|
1346605-26-2
|
C16H9D3O6
|
|
2-(1-Hydroxyethyl) ProMazine-d4 Sulfoxide
|
1346605-30-8
|
C19H24N2O2S
|
|
Tadalafil KetolactaM
|
1346605-38-6
|
C22H19N3O6
|
|
Balsalazide Isopropyl Ester
|
1346606-13-0
|
C20H21N3O6
|
|
3-[2-[4-[(Z)-(4-Fluoro-2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl)phenyl](hydroxyiMino)Methyl]piperidin-1-yl]ethyl]-2-Methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyriMidin-4-one (Risperidone IMpurity)
|
1346606-24-3
|
C35H40F2N6O3
|
|
3-Oxo Rosuvastatin SodiuM Salt
|
1346606-28-7
|
C22H26FN3O6S.Na
|
|
Desbutyl LuMefantrine-d9
|
1346606-35-6
|
C26H15D9Cl3NO
|
|
Azoxystrobin-d4
|
1346606-39-0
|
C22H17N3O5
|
|
LoprazolaM-d8
|
1346606-41-4
|
C23H21ClN6O3
|
|
3-AMino-6-chloro-4-(4-pyridinyl)-2-quinolinone Hydrazone
|
1346606-48-1
|
C15H13ClN4
|
|
Sulfasalazine-d4
|
1346606-50-5
|
C18H14N4O5S
|
|
TaMoxifen DiMer
|
1346606-51-6
|
C49H49NO2
|
|
2'-[(1E)-2-[4-[[(2-carboxyethyl)aMino]carbonyl]phenyl]diazenyl] Balsalazide
|
1346606-53-8
|
C27H24N6O9
|
|
Chlorfenvinphos-d10
(Mixture of cis-trans isoMers)
|
1346606-54-9
|
C12H4Cl3D10O4P
|
|
2-O-[4-[[(2-carboxyethyl)aMino]carbonyl]phenyl] Balsalazide
|
1346606-62-9
|
C27H24N4O9
|
|
(E)-5-(3-AMinophenyl)-2-penten-4-ynoic Acid Ethyl Ester Trifluoroacetic Acid Salt
|
1346606-68-5
|
C15H14F3NO4
|
|
GSK621
|
1346607-05-3
|
C26H20ClN3O5
|
|
1-Methyl-1h-pyrrolo[3,2-b]pyridine-3-carboxylic acid
|
1346608-64-7
|
C9H8N2O2
|
|
2-Fluoro-3-isopropoxybenzoic acid
|
1346608-65-8
|
C10H11FO3
|
|
(R)-1-AMinoindane-d3 Hydrochloride
|
1346616-96-3
|
C9H12ClN
|
|
(R)-Amlodipine-d4
|
1346616-97-4
|
C20H21D4ClN2O5
|
|
(αR)-N-(Methyl-d3)-α-Methyl-N-2-propyn-1-yl-benzeneethanaMine N-Oxide
|
1346616-99-6
|
C13H17NO
|
|
15N2, 98%)
|
1346617-00-2
|
C5H13ClN2O2
|
|
(S)-Azelastine N-Oxide (Mixture of DiastereoMers)
|
1346617-06-8
|
C22H24ClN3O2
|
|
(R)-2-Methylbutyric Acid-d3
|
1346617-08-0
|
C5H7D3O2
|
|
N-t-Boc-valacyclovir-d4
|
1346617-11-5
|
C18H28N6O6
|
|
(R)-Azelastine N-Oxide (Mixture of DiastereoMers)
|
1346617-18-2
|
C22H24ClN3O2
|
|
Escitalopram Desfluoro Analogue
|
1346617-30-8
|
C20H22N2O
|
|
Acyclovir N-Methyl-L-valinate Hydrochloride
|
1346617-39-7
|
C14H23ClN6O4
|
|
(S)-4,5,6,7-Tetrahydro-N2,N6-propionyl-2,6-benzothiazolediaMine
|
1346617-47-7
|
C13H19N3O2S
|
|
Acyclovir N-Ethyl-L-valinate Hydrochloride
|
1346617-49-9
|
C15H24N6O4.ClH
|
|
Tris(4-(2H-tetrazol- 5-yl)phenyl)amine
|
1346621-21-3
|
C21H15N13
|
|
Budiodarone tartrate
|
1346623-17-3
|
C33H35F4N3O2
|
|
Potassium cyclohexylmethyltrilfuoroborate
|
1346647-18-4
|
C7H12BF3K
|
|
9-[1,1'-biphenyl]-4-yl-3,3'-Bi-9H-carbazole
|
1346669-48-4
|
C36H24N2
|
|
3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-1(2H)-one
|
1346672-36-3
|
C11H14N2O
|
|
3,4,6,7,8,9-hexahydropyrido[3,4-b]indolizin-1(2H)-one
|
1346672-96-5
|
C11H14N2O
|
|
5-(1-methylpiperidin-4-yl)pyridin-2-amine
|
1346673-25-3
|
C11H17N3
|
|
tert-Butyl 3-(6-aminopyridin-3-yl)azetidine-1-carboxylate
|
1346673-86-6
|
C13H19N3O2
|
|
Ethyl 1-BOC-azetidine-3-carboxylate
|
1346674-10-9
|
C11H19NO4
|
|
tert-butyl 3-(3-amino-1H-pyrazol-5-yl)azetidine-1-carboxylate
|
1346674-11-0
|
C11H18N4O2
|
|
Ethyl 5,5-dimethyl-1,4,5,6-tetrahydrocyclopenta[b]pyrrole-2-carboxylate
|
1346674-20-1
|
C12H17NO2
|
|
3,4,7,8-tetrahydro-7,7-dimethyl-2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one
|
1346674-23-4
|
C12H16N2O
|
|
(2,6-dibroMo-4-fluorophenyl)Methanol
|
1346674-69-8
|
C7H5Br2FO
|
|
3-[[3,5-bis(trifluoroMethyl)phenyl]aMino]-4-[[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]aMino]-
|
1346683-42-8
|
C22H23F6N3O2
|
|
(5-(furan-3-yl)pyridin-3-yl)methanol
|
1346687-20-4
|
C10H9NO2
|
|
(5-(pyrimidin-2-yl)pyridin-3-yl)methanol
|
1346687-30-6
|
C10H9N3O
|
|
5-(PyriMidin-5-yl)nicotinaldehyde
|
1346687-35-1
|
C10H7N3O
|
|
(5-(pyrimidin-5-yl)pyridin-3-yl)methanamine
|
1346687-36-2
|
C10H10N4
|
|
2,6-dibroMo-4-octyldithieno[3,2-d:3',2'-e]pyrrole
|
1346688-54-7
|
C16H19Br2NS2
|
|
1-(4-bromophenyl)cyclopentanemethanol
|
1346689-83-5
|
C12H15BrO
|
|
3-chloro-5-cyclopropoxypyridazine
|
1346691-24-4
|
C7H7ClN2O
|
|
3-chloro-5-(cyclopropylmethoxy)pyridazine
|
1346691-28-8
|
C8H9ClN2O
|
|
5-(benzyloxy)-3-chloropyridazine
|
1346691-32-4
|
C11H9ClN2O
|
|
3-chloro-5-(2,2,2-trifluoroethoxy)pyridazine
|
1346691-33-5
|
C6H4ClF3N2O
|
|
5-bromo-4-cyclopropylpyrimidine
|
1346697-39-9
|
C7H7BrN2
|
|
5-bromo-4-(cyclopropylmethyl)pyrimidine
|
1346697-40-2
|
C8H9BrN2
|
|
3-chloro-5-propoxypyridazine
|
1346698-30-3
|
C7H9ClN2O
|
|
3-chloro-5-isopropoxypyridazine
|
1346698-31-4
|
C7H9ClN2O
|
|
5-tert-butoxy-3-chloropyridazine
|
1346698-35-8
|
C8H11ClN2O
|
|
Methyl 6-broMo-l-(l- Methylethyl)-lH-indazole-4-carboxylate
|
1346702-52-0
|
C12H13BrN2O2
|
|
Methyl 6-broMo-2-isopropyl-2H-indazole-4-carboxylate
|
1346702-53-1
|
C12H13BrN2O2
|
|
6-Bromo-1-isopropyl-1H-indazole-4-carboxylic acid
|
1346702-54-2
|
C11H11BrN2O2
|
|
1H-Indazole-4-carboxaMide,6-broMo-1-cyclopentyl-N-[(1,2-dihydro-4,6-diMethyl-2-oxo-3-pyridinyl)Methyl]-
|
1346703-22-7
|
C21H23BrN4O2
|
|
GSK 343
|
1346704-33-3
|
C31H39N7O2
|
|
2-(3-Cyclopentyloxy-phenyl)-4,4,5,5-tetraMethyl-[1,3,2]dioxaborolane
|
1346706-39-5
|
C17H25BO3
|
|
2-isobutoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
|
1346707-87-6
|
C15H24BNO3
|
|
2-cyclopropoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
|
1346707-95-6
|
C14H20BNO3
|
|
2-(cyclohexyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
|
1346707-98-9
|
C17H26BNO3
|
|
2-(cyclopropylmethoxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
|
1346707-99-0
|
C15H22BNO3
|
|
2-(cyclobutylmethoxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
|
1346708-00-6
|
C16H24BNO3
|
|
2-(4-chloropyridin-2-yloxy)ethanamine
|
1346708-15-3
|
C7H9ClN2O
|
|
EsMolol-d7 HCl
|
1346746-38-0
|
C16H25NO4
|
|
phenylethanolaMine A
|
1346746-81-3
|
C19H24N2O4
|
|
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, rel-
|
1346747-14-5
|
C21H24FN3O4
|
|
Fingolimod-d4
|
1346747-38-3
|
C19H33NO2
|
|
Valaciclovir Ep Impurity C
|
1346747-65-6
|
C14H22N6O4
|
|
Valaciclovir iMpurity D
|
1346747-69-0
|
C15H24N6O4
|
|
YHO-13351
|
1346753-00-1
|
C27H37N3O7S2
|
|
2-(9-Oxoxanthen-2-yl)propionic Acid 1,5-Diazabicyclo[4.3.0]non-5-ene Salt
|
1346753-04-5
|
C23H24N2O4
|
|
2-(9-Oxoxanthen-2-yl)propionic Acid 1,8-Diazabicyclo[5.4.0]undec-7-ene Salt
|
1346753-05-6
|
C25H28N2O4
|
|
2-(9-Oxoxanthen-2-yl)propionic Acid 1,5,7-Triazabicyclo[4.4.0]dec-5-ene Salt
|
1346753-09-0
|
C23H25N3O4
|
|
(R)-tert-butyl 5-oxopyrrolidin-3-ylcarbaMate
|
1346773-63-4
|
C9H16N2O3
|
|
2-bromo-1,3,4-Oxadiazole
|
1346808-29-4
|
C2HBrN2O
|
|
2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,4-oxadiazole
|
1346808-32-9
|
C8H13BN2O3
|
|
5-Methyl-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)isoxazole
|
1346808-41-0
|
C10H16BNO3
|
|
3-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)isoxazole
|
1346808-44-3
|
C10H16BNO3
|
|
N-cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
|
1346808-54-5
|
C16H25BN2O2
|
|
3-fluoro-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine hydrochloride
|
1346808-65-8
|
C7H8ClFN2
|
|
2-N, N-(Bis-Boc-aMino)-3-Methylpyridine-5-boronic acid pinacol ester
|
1346808-71-6
|
C22H35BN2O6
|
|
2,2'-oxybis(methylene)bis(4-(trifluoromethyl)pyrimidine)
|
1346808-72-7
|
C12H8F6N4O
|
|
2-Methyl-5,8-dihydro-6H-pyrido[3,4-d]pyriMidine-7-carboxylic acid tert-butyl ester
|
1346808-81-8
|
C13H19N3O2
|
|
1-(5-broMopyriMidin-2-yl)propan-1-one
|
1346808-91-0
|
C7H7BrN2O
|
|
tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)piperazine-1-carboxylate
|
1346808-98-7
|
C20H32BN3O4
|